Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders

Clonidine has been used off-label in children and adolescents with attention deficit and hyperactivity disorders (ADHD) with or without comorbidities. Clonidine extended-release was recently approved by the US Food and Drug Administration for ADHD in children. This review evaluates the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ming, Xue, Mulvey, Martha, Mohanty, Sharanya, Patel, Viraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926778/
https://www.ncbi.nlm.nih.gov/pubmed/24600280
http://dx.doi.org/10.2147/AHMT.S15672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926778/
https://www.ncbi.nlm.nih.gov/pubmed/24600280
http://dx.doi.org/10.2147/AHMT.S15672

Ejemplares similares